Gene · 3937
Papers1,973
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 1,973
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of CDCA8, DSN1 and BIRC5 in Regulating Cell Cycle and Apoptosis in Osteosarcoma Using Bioinformatics and Cell Biology. | Technol Cancer Res Treat | 2020 | 33153400 | PubTator, text mining | PubMed |
| Mitochondria Synergize With P2 Receptors to Regulate Human T Cell Function. | Front Immunol | 2020 | 33133068 | PubTator, text mining | PubMed |
| The Oncometabolite 5'-Deoxy-5'-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation. | Front Immunol | 2020 | 33123121 | PubTator, text mining | PubMed |
| OsteoBLAST: Computational Routine of Global Molecular Analysis Applied to Biomaterials Development. | Front Bioeng Biotechnol | 2020 | 33117780 | PubTator, text mining | PubMed |
| Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets. | Front Oncol | 2020 | 33117683 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions. | J Biol Chem | 2020 | 33077516 | PubTator, text mining | PubMed |
| Transcriptome Profiling of Human Monocyte-Derived Macrophages Upon CCL2 Neutralization Reveals an Association Between Activation of Innate Immune Pathways and Restriction of HIV-1 Gene Expression. | Front Immunol | 2020 | 33072075 | PubTator, text mining | PubMed |
| Increased Protein Stability and Interleukin-2 Production of a LATG131D Variant With Possible Implications for T Cell Anergy. | Front Cell Dev Biol | 2020 | 33042995 | PubTator, text mining | PubMed |
| Transcriptome-Based Network Analysis Unveils Eight Immune-Related Genes as Molecular Signatures in the Immunomodulatory Subtype of Triple-Negative Breast Cancer. | Front Oncol | 2020 | 33042828 | PubTator, text mining | PubMed |
| TILRR (FREM1 isoform 2) is a prognostic biomarker correlated with immune infiltration in breast cancer. | Aging (Albany NY) | 2020 | 33031059 | PubTator, text mining | PubMed |
| TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma. | FEBS Open Bio | 2020 | 33015999 | PubTator, text mining | PubMed |
| Identification of TYROBP and C1QB as Two Novel Key Genes With Prognostic Value in Gastric Cancer by Network Analysis. | Front Oncol | 2020 | 33014868 | PubTator, text mining | PubMed |
| Surfing on Membrane Waves: Microvilli, Curved Membranes, and Immune Signaling. | Front Immunol | 2020 | 33013920 | PubTator, text mining | PubMed |
| The membrane proximal proline-rich region and correct order of C-terminal tyrosines on the adaptor protein LAT are required for TCR-mediated signaling and downstream functions. | Cell Signal | 2020 | 32979494 | PubTator, text mining | PubMed |
| Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. | Signal Transduct Target Ther | 2020 | 32958760 | PubTator, text mining | PubMed |
| Model-based clustering for flow and mass cytometry data with clinical information. | BMC Bioinformatics | 2020 | 32938365 | PubTator, text mining | PubMed |
| GTF2IRD1 overexpression promotes tumor progression and correlates with less CD8+ T cells infiltration in pancreatic cancer. | Biosci Rep | 2020 | 32936232 | PubTator, text mining | PubMed |
| IRF1-mediated immune cell infiltration is associated with metastasis in colon adenocarcinoma. | Medicine (Baltimore) | 2020 | 32925784 | PubTator, text mining | PubMed |
| Mining of prognosis-related genes in cervical squamous cell carcinoma immune microenvironment. | PeerJ | 2020 | 32904067 | PubTator, text mining | PubMed |
| A perspective on HPK1 as a novel immuno-oncology drug target. | Elife | 2020 | 32896273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3937/papers?page=32